Lenz Robert A. insider trades
Lenz Robert A. has filed 10 Form 4s with the SEC that we hold, for Neumora Therapeutics, Inc. (NMRA) (Head of R&D), Lb Pharmaceuticals INC (LBRX) (Director) and NovaBridge Biosciences (NBP) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $1.1M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 32,948 shares of Neumora Therapeutics, Inc. worth $376.6K, dated 2024-09-12. The first filing on our record is dated 2023-09-18 and the latest 2026-08-25.
Neumora Therapeutics, Inc. (NMRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-12 | S, sale reported on Form 4 | 32,948 | $376.6K | 2024-09-16 |
| 2024-09-17 | S, sale reported on Form 4 | 30,788 | $363.6K | 2024-09-19 |
| 2024-09-18 | S, sale reported on Form 4 | 10,676 | $129.1K | 2024-09-19 |
| 2024-10-09 | S, sale reported on Form 4 | 5,563 | $83.5K | 2024-10-11 |
| 2024-10-10 | S, sale reported on Form 4 | 8,260 | $124.6K | 2024-10-11 |
| 2025-02-18 | S, sale reported on Form 4 | 5,614 | $9.4K | 2025-02-20 |
Lb Pharmaceuticals INC (LBRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
NovaBridge Biosciences (NBP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1992908) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms